0
Letters |

Should β-Blockers Be Used to Treat Hypertension in Elderly Patients?—Reply

Thomas G. Pickering, MD, DPhil
JAMA. 1999;281(21):1988-1989. doi:10-1001/pubs.JAMA-ISSN-0098-7484-281-21-jbk0602.
Text Size: A A A
Published online

Extract

In Reply: While it is true that both β-blockers and diuretics are recommended by JNC VI, the report states, "When compared with each other, diuretics (hydrochlorothiazide with amiloride hydrochloride) are superior to the β-blocker atenolol. In older patients with isolated systolic hypertension, diuretics are preferred because they significantly reduce multiple end-point events."1 One reason diuretics may be superior is that a major pathological component of hypertension in the elderly is decreased arterial compliance, which leads to a selective increase of systolic pressure as a result of accelerated reflection of the arterial pulse wave from the periphery.2 Peripheral resistance is increased, and cardiac output is low. β-Blockade lowers cardiac output; furthermore, in younger patients with systolic hypertension, acute β-blockade lowers blood pressure without affecting arterial compliance, whereas in older patients, compliance is decreased and blood pressure is unchanged.3 In elderly patients with systolic hypertension, diuretic treatment lowers peripheral resistance without affecting cardiac output.4 Thus, there are theoretical as well as practical reasons for believing that diuretic treatment is preferable to treatment with β-blockers in elderly patients with uncomplicated hypertension.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs